- Public Health England
- Part of:
- Meningococcal B (MenB) vaccination programme, Meningococcal ACWY (MenACWY) vaccination programme, and Immunisation
- 3 August 2015
These slides provide detailed training for health professionals on the new meningococcal B and meningococcal ACWY immunisation programmes.
MS Powerpoint Presentation, 7.03MB
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This is an advanced training slideset aimed at healthcare professionals on the MenB and MenACWY immunisation programmes.
The MenACWY vaccine is being introduced in response to an increase in cases of invasive meningococcal disease capsular group W (MenW) disease. This vaccine will provide direct protection to the vaccinated cohort and, by reducing carriage of MenW, will also provide indirect protection to unvaccinated children and adults.
The new MenB vaccine (Bexsero®) will protect against meningococcal disease capsular group B. The vaccine will be added to the childhood immunisation programme as part of the routine schedule in England from 1 September 2015.
Published: 3 August 2015